In addition, LSD1 inhibitors can sensitize SCLC cells to anti–PD-L1 blockade and have shown an additive antiproliferative effect when combined with YAP inhibitors in oral squamous cell carcinoma cells (122, 123). Here, KDM1A is linked to small cell lung carcinoma.